liberDi was founded to meet the market need for an easy-to-use, at-home dialysis system that improves treatment benefits and reduces health care costs. liberDi is developing its automatic peritoneal dialysis (PD) system that promises easy setup. The Company anticipates that the system will allow an increasing number of people requiring dialysis to enjoy the benefits of home treatment. Company founder and CEO is Hezkiah Tsoory, who has more than 22 years of experience in business, operations, and R&D.
The liberDi Mission
liberDi aims to be the leader in the field of portable PD systems, with a groundbreaking treatment option that will significantly improve the quality of life for people with end-stage renal disease (ESRD).
Over 20 years’ experience as Specialist in Nephrology and Hypertension.Head, Department of Nephrology and Hypertension, Carmel Medical Center.Vice-President, the Israeli Society of Nephrology and Hypertension.Chairman, Nephrology Technologies Committee, Clalit Health System.
Specialist in Nephrology and Internal Medicine.20 years’ experience, in the nephrology field.Head of Dialysis Unit Carmel Medical Center-Haifa, Israel
Specialist in Nephrology and Internal Medicine. Extensive clinical and research experience in the field of Nephrology in general, and in Peritoneal Dialysis in particular
Head of the Institute of Nephrology, Rabin Medical Center (Beilinson & Hasharon hospitals), Petah Tikva, Israel
Head of peritoneal dialysis unit, Imperial College Kidney and Transplant Centre, Hammersmith Hospital, London, UK. Co-organiser of UK PD Academy. Extensive research and education related to outcomes of older patients on dialysis. Chair of the guidelines committee, International Society of Peritoneal Dialysis.